LeMaitre Vascular Inc (LMAT) stock
Close on Nov 12, 2026Market cap $1.78BP/E 28.2Yield 1.03%
LeMaitre Vascular Inc grew revenue 11.8% to $269.36M over the twelve months to Sep 30, 2026. Operating income rose 20.6% to $74.70M, moving the operating margin from 25.7% to 27.7%. Free cash flow was $67.00M, up 1.2% from a year earlier. At the latest close the market valued the company at $1.78B, 28.2 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.78B
- P/E ratio
- 28.2
- Price to sales
- 6.59
- Price to book
- 4.11
- Dividend yield
- 1.03%
- Free cash flow yield
- 3.77%
Fundamentals
- Revenue
- $269.36M
- Net income
- $63.34M
- EPS, diluted
- $2.75
- Free cash flow
- $67.00M
- Book value per share
- $18.73
- Diluted shares
- 23M
Trading
- Next earnings
- Feb 24, 2027 (estimated, after the close)
- Previous close
- $79.29
- Open
- $79.41
- Day's range
- $77.46 – $79.76
- Volume
- 166,323
- Average volume (20 days)
- 292,643
- Index membership
- S&P SmallCap 600, Russell 2000, Russell 3000
- Beta (5 years)
- 0.58
- 52-week range
- $78.22 – $118.01
- RSI (14 days)
- 43.7
- Volatility (1 year)
- 46.3%
- Relative volume
- 0.43×
- WACC
- 7.8%
On 1 of our idea list: Dividend growers
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | LMAT | S&P 500 | Difference | LMAT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -6.3% | -2.7% | −3.6 pts | ||
| 3 months | -5.2% | -1.7% | −3.4 pts | ||
| Year to date | -3.5% | +11.9% | −15.4 pts | ||
| 1 year | -12.8% | +12.0% | −24.8 pts | ||
| 3 years | +64.4% | +78.2% | −13.8 pts | +18.0% | +21.2% |
| 5 years | +49.6% | +73.2% | −23.6 pts | +8.4% | +11.6% |
| 10 years | +258.9% | +309.6% | −50.7 pts | +13.6% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases LeMaitre Vascular filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About LeMaitre Vascular
Surgical & Medical Instruments & Apparatus
LeMaitre Vascular, Inc. is a medical device company that develops, manufactures, and markets vascular devices and provides human tissue cryopreservation services. Its products are primarily designed for use in open surgical procedures, including open vascular and open cardiac surgeries, to treat peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company's portfolio features six product categories encompassing twenty-four distinct product types, such as valvulotomes, balloon catheters, carotid shunts, vascular grafts, patches, and vessel closure systems. LeMaitre Vascular primarily serves vascular surgeons, while also providing products and tissue processing services to cardiac surgeons, general surgeons, and neurosurgeons.
Company profile, executives and historyLeMaitre Vascular stock: common questions
What is LeMaitre Vascular's stock price?
LMAT closed at $77.65 on Nov 12, 2026, down 2.07% on the day. Over the past 52 weeks it traded between $78.22 and $118.01.
What is LeMaitre Vascular's market cap?
LeMaitre Vascular was worth $1.78B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is LMAT's P/E ratio?
LMAT trades at 28.2 times earnings, based on diluted earnings per share of $2.75 over the twelve months to Sep 30, 2026.
How much revenue does LeMaitre Vascular make?
LeMaitre Vascular reported revenue of $269.36M for the twelve months to Sep 30, 2026, up 11.8% from a year earlier.
Does LeMaitre Vascular pay a dividend?
Yes. LeMaitre Vascular paid $0.80 per share over the last twelve months, a yield of 1.03% at the latest price, and has raised its annual dividend 14 years in a row.
When does LeMaitre Vascular report earnings next?
LeMaitre Vascular is expected to report Q4 FY2026 results on Feb 24, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has LMAT stock performed over the past year?
Including dividends, LMAT returned -12.8% over the past year, against +12.0% for the S&P 500.
How many LMAT shares are sold short?
2M shares were sold short at the latest FINRA report, 7.96% of the float, or 6.2 days of average trading volume.
Who are LeMaitre Vascular's competitors?
Companies most similar to LeMaitre Vascular by business, industry and size include ANGO, AORT, MDXG, ATRC, KIDS.
See a number that looks wrong?